Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 135 Pages
Report ld: 6892400
Request Sample
Customized Report
The global market for Fentanyl API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Fentanyl API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Fentanyl API market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Fentanyl API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Fentanyl API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Fentanyl API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Fentanyl API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fentanyl API Product Introduction
1.2 Global Fentanyl API Market Size Forecast
1.2.1 Global Fentanyl API Sales Value (2021–2032)
1.2.2 Global Fentanyl API Sales Volume (2021–2032)
1.2.3 Global Fentanyl API Sales Price (2021–2032)
1.3 Fentanyl API Market Trends & Drivers
1.3.1 Fentanyl API Industry Trends
1.3.2 Fentanyl API Market Drivers & Opportunities
1.3.3 Fentanyl API Market Challenges
1.3.4 Fentanyl API Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fentanyl API Players Revenue Ranking (2025)
2.2 Global Fentanyl API Revenue by Company (2021–2026)
2.3 Global Fentanyl API Sales Volume Ranking of Players (2025)
2.4 Global Fentanyl API Sales Volume by Company (2021–2026)
2.5 Global Fentanyl API Average Price by Company (2021–2026)
2.6 Key Manufacturers Fentanyl API Manufacturing Base and Headquarters
2.7 Key Manufacturers Fentanyl API Product Offerings
2.8 Key Manufacturers Start of Mass Production of Fentanyl API
2.9 Fentanyl API Market Competitive Analysis
2.9.1 Fentanyl API Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Fentanyl API Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Fentanyl API revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Fentanyl API Market Classification
3.1 Introduction by Type
3.1.1 Purity 98%
3.1.2 Purity 99%
3.1.3 Global Fentanyl API Sales Value by Type
3.1.3.1 Global Fentanyl API Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Fentanyl API Sales Value, by Type (2021–2032)
3.1.3.3 Global Fentanyl API Sales Value, by Type (%), 2021–2032
3.1.4 Global Fentanyl API Sales Volume by Type
3.1.4.1 Global Fentanyl API Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Fentanyl API Sales Volume, by Type (2021–2032)
3.1.4.3 Global Fentanyl API Sales Volume, by Type (%), 2021–2032
3.1.5 Global Fentanyl API Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Lollipop
4.1.3 Spray
4.1.4 Injectant
4.1.5 Others
4.2 Global Fentanyl API Sales Value by Application
4.2.1 Global Fentanyl API Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Fentanyl API Sales Value, by Application (2021–2032)
4.2.3 Global Fentanyl API Sales Value, by Application (%), 2021–2032
4.3 Global Fentanyl API Sales Volume by Application
4.3.1 Global Fentanyl API Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Fentanyl API Sales Volume, by Application (2021–2032)
4.3.3 Global Fentanyl API Sales Volume, by Application (%), 2021–2032
4.4 Global Fentanyl API Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Fentanyl API Sales Value by Region
5.1.1 Global Fentanyl API Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Fentanyl API Sales Value by Region (2021–2026)
5.1.3 Global Fentanyl API Sales Value by Region (2027–2032)
5.1.4 Global Fentanyl API Sales Value by Region (%), 2021–2032
5.2 Global Fentanyl API Sales Volume by Region
5.2.1 Global Fentanyl API Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Fentanyl API Sales Volume by Region (2021–2026)
5.2.3 Global Fentanyl API Sales Volume by Region (2027–2032)
5.2.4 Global Fentanyl API Sales Volume by Region (%), 2021–2032
5.3 Global Fentanyl API Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Fentanyl API Sales Value, 2021–2032
5.4.2 North America Fentanyl API Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Fentanyl API Sales Value, 2021–2032
5.5.2 Europe Fentanyl API Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Fentanyl API Sales Value, 2021–2032
5.6.2 Asia Pacific Fentanyl API Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Fentanyl API Sales Value, 2021–2032
5.7.2 South America Fentanyl API Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fentanyl API Sales Value, 2021–2032
5.8.2 Middle East & Africa Fentanyl API Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fentanyl API Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Fentanyl API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Fentanyl API Sales Value, 2021–2032
6.2.2 Key Countries/Regions Fentanyl API Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Fentanyl API Sales Value, 2021–2032
6.3.2 United States Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Fentanyl API Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Fentanyl API Sales Value, 2021–2032
6.4.2 Europe Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Fentanyl API Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Fentanyl API Sales Value, 2021–2032
6.5.2 China Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.5.3 China Fentanyl API Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Fentanyl API Sales Value, 2021–2032
6.6.2 Japan Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Fentanyl API Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Fentanyl API Sales Value, 2021–2032
6.7.2 South Korea Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Fentanyl API Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Fentanyl API Sales Value, 2021–2032
6.8.2 Southeast Asia Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Fentanyl API Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Fentanyl API Sales Value, 2021–2032
6.9.2 India Fentanyl API Sales Value by Type (%), 2025 vs 2032
6.9.3 India Fentanyl API Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Company Information
7.1.2 Mylan Introduction and Business Overview
7.1.3 Mylan Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Mylan Fentanyl API Product Offerings
7.1.5 Mylan Recent Developments
7.2 AMRI
7.2.1 AMRI Company Information
7.2.2 AMRI Introduction and Business Overview
7.2.3 AMRI Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 AMRI Fentanyl API Product Offerings
7.2.5 AMRI Recent Developments
7.3 Cambrex
7.3.1 Cambrex Company Information
7.3.2 Cambrex Introduction and Business Overview
7.3.3 Cambrex Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Cambrex Fentanyl API Product Offerings
7.3.5 Cambrex Recent Developments
7.4 Rusan Pharma
7.4.1 Rusan Pharma Company Information
7.4.2 Rusan Pharma Introduction and Business Overview
7.4.3 Rusan Pharma Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Rusan Pharma Fentanyl API Product Offerings
7.4.5 Rusan Pharma Recent Developments
7.5 Johnson Matthey
7.5.1 Johnson Matthey Company Information
7.5.2 Johnson Matthey Introduction and Business Overview
7.5.3 Johnson Matthey Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Johnson Matthey Fentanyl API Product Offerings
7.5.5 Johnson Matthey Recent Developments
7.6 Northern Synthesis
7.6.1 Northern Synthesis Company Information
7.6.2 Northern Synthesis Introduction and Business Overview
7.6.3 Northern Synthesis Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Northern Synthesis Fentanyl API Product Offerings
7.6.5 Northern Synthesis Recent Developments
7.7 Mallinckrodt
7.7.1 Mallinckrodt Company Information
7.7.2 Mallinckrodt Introduction and Business Overview
7.7.3 Mallinckrodt Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Mallinckrodt Fentanyl API Product Offerings
7.7.5 Mallinckrodt Recent Developments
7.8 Arevipharma GmbH
7.8.1 Arevipharma GmbH Company Information
7.8.2 Arevipharma GmbH Introduction and Business Overview
7.8.3 Arevipharma GmbH Fentanyl API Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Arevipharma GmbH Fentanyl API Product Offerings
7.8.5 Arevipharma GmbH Recent Developments
8 Industry Chain Analysis
8.1 Fentanyl API Industrial Chain
8.2 Fentanyl API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Fentanyl API Sales Model
8.5.2 Sales Channels
8.5.3 Fentanyl API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fentanyl API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 131
USD 2900.00
(Single User License)
The global Fentanyl API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 141
USD 4900.00
(Single User License)
The global market for Fentanyl API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 101
USD 3950.00
(Single User License)
The global market for Fentanyl API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 94
USD 2900.00
(Single User License)
The global Fentanyl API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 78
USD 4250.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-04-07
Pages: 88
USD 4900.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-02-19
Pages: 101
USD 3950.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-01-11
Pages: 93
USD 2900.00
(Single User License)
The global Fentanyl API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 131
The global Fentanyl API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 141
The global market for Fentanyl API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 101
The global market for Fentanyl API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 94
The global Fentanyl API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 78
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-04-07
Pages: 88
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-02-19
Pages: 101
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-01-11
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now